4.6 Article

Tumor-associated fibrosis impairs the response to immunotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Infiltrating CD8+T cells and M2 macrophages are retained in tumor matrix tracks enriched in low tension fibronectin fibers

Charlotte M. Fonta et al.

Summary: Immunostainings of mouse breast tumors reveal that tumor matrix tracks, with immunosuppressive functions, are surrounded by an endothelial-like basement membrane and contain collagen and fibronectin fibers. These tracks form in early-stage tumors and mature over time, and their maturation depends on host-derived tenascin-C (TNC). Tumor infiltrating leukocytes, mainly M2 macrophages and CD8+ T cells, are retained in early-stage tumor tracks but reduce in number after track maturation.

MATRIX BIOLOGY (2023)

Article Biochemistry & Molecular Biology

CAR-T Cells in the Treatment of Ovarian Cancer: A Promising Cell Therapy

Xi-Wen Zhang et al.

Biomolecules (2023)

Review Oncology

Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies

Nisha Kumari et al.

Summary: Cancer immunotherapy has had limited success, but nanoparticles have emerged as crucial tools in targeting tumor-associated macrophages (TAMs) and improving therapy outcomes. Current strategies include restricting TAMs survival, inhibiting TAMs recruitment, and repolarizing tumor-supportive TAMs to an antitumor phenotype.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Gastroenterology & Hepatology

Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity

Tu-Xiong Huang et al.

Summary: Solid tumours have poor response to ICI therapies due to the immunosuppressive TME, where CAFs play a key role in negatively regulating antitumor T-cell responses. Targeting WNT2 secreted by CAFs could enhance ICI efficacy and serve as a new approach for anticancer immunotherapy.
Review Oncology

Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment

James L. Gulley et al.

Summary: Transforming growth factor-beta (TGF-beta) and programmed death-ligand 1 (PD-L1) have immunosuppressive functions in the tumor microenvironment (TME) and inhibiting these pathways can improve clinical outcomes and reduce toxicity.

MOLECULAR ONCOLOGY (2022)

Article Oncology

Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer

Huocong Huang et al.

Summary: Recent studies have identified a unique population of cancer-associated fibroblasts (apCAFs) derived from mesothelial cells, which play a critical role in pancreatic cancer progression. These apCAFs directly induce naive CD4(+) T cells to differentiate into regulatory T cells (Tregs) in an antigen-specific manner.

CANCER CELL (2022)

Article Gastroenterology & Hepatology

CXCR2 inhibition enables NASH-HCC immunotherapy

Jack Leslie et al.

Summary: This study found that targeting neutrophils using a CXCR2 small molecule inhibitor can enhance the sensitivity of non-alcoholic steatohepatitis-associated hepatocellular carcinoma (NASH-HCC) to immune checkpoint inhibition therapy (ICI). The combination therapy can reprogram the tumor immune microenvironment, increase the number of anti-tumor immune cells, and improve treatment outcomes.
Review Oncology

Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy

Yangfu Jiang et al.

Summary: The cancer microenvironment plays a critical role in tumorigenesis and cancer progression. The interaction between the extracellular matrix (ECM) and tumor and stromal cells contributes to cancer cell proliferation, migration, invasion, angiogenesis, and immune evasion. Both ECM stiffness itself and ECM stiffening-induced mechanical stimuli can activate cell membrane receptors and mechanosensors, thereby modulating the malignant phenotype of tumor and stromal cells. Understanding how ECM stiffness regulates tumor progression is crucial for the development of new therapeutics.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

Modulating tenascin-C functions by targeting the MAtrix REgulating MOtif, MAREMO

Thomas Loustau et al.

Summary: The extracellular matrix molecule Tenascin-C (TNC) promotes cancer and chronic inflammation through various mechanisms and contributes to an immune suppressive tumor microenvironment. Research has identified a highly conserved MAtrix REgulating MOtif (MAREMO) or M-motif in fibronectin and TNC. Mimetic peptides of the M-motif have been found to inhibit the functions of TNC.

MATRIX BIOLOGY (2022)

Review Immunology

A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance

Alexander C. Huang et al.

Summary: Enormous progress has been made in the treatment of melanoma using immune checkpoint blockade in the past ten years. This review discusses the current understanding of the melanoma immune microenvironment and explores novel approaches to enhance the efficacy of immunotherapies. It also highlights the negative impact of melanoma metabolic adaptation on anti-tumor immunity and proposes ways to counteract these mechanisms for more effective use of immunotherapy.

NATURE IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Metabolic reprogramming of tumor-associated macrophages by collagen turnover promotes fibrosis in pancreatic cancer

Madeleine M. LaRue et al.

Summary: Tumor-associated macrophages play a role in remodeling the extracellular matrix, which affects the growth and development of tumors.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Oncology

Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer

Kathleen M. McAndrews et al.

Summary: The study identifies two distinct populations of fibroblasts with opposing roles in the progression and immune landscape of PDAC. Fibroblasts play diverse functions in regulating cancer-associated pathways and accumulation of regulatory T cells, impacting therapeutic efficacy in PDAC treatment. This finding reveals the functional heterogeneity of CAFs in PDAC progression, with significant implications for therapy response.

CANCER DISCOVERY (2022)

Review Pharmacology & Pharmacy

Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within

Abdul Basit Baba et al.

Summary: The ubiquitously expressed cytokine transforming growth factor-beta (TGF-beta) plays a significant role in cellular mechanisms. It functions as a tumor suppressor at the early onset of malignancy but promotes tumorigenesis at an advanced stage. Moreover, TGF-beta regulates cell fate through immune and stroma components.

FRONTIERS IN PHARMACOLOGY (2022)

Article Oncology

Coordinated Regulation of Myeloid-Derived Suppressor Cells by Cytokines and Chemokines

Ru Li et al.

Summary: In this review, the effects of cytokines and chemokines on myeloid-derived suppressor cells in cancer metastasis are summarized. Cytokines and chemokines in the tumor microenvironment alter the functional properties of MDSCs and are involved in their production, infiltration, and immunosuppressive functions. The manipulation of MDSCs by tumors through cytokine and chemokine signaling is discussed, as well as potential treatment strategies targeting these signaling pathways to combat the immunosuppressive activities of MDSCs and improve disease outcomes.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Comprehensive Analysis on Prognosis and Immune Infiltration of Lysyl Oxidase Family Members in Pancreatic Adenocarcinoma With Experimental Verification

Chao Jiang et al.

Summary: The study revealed that the LOX family, especially LOX and LOXL2, play a significant role in PDAC and may serve as prognostic biomarkers, opening up a new direction for targeted therapy.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Review Oncology

Cancer-associated fibroblasts in breast cancer: Challenges and opportunities

Dengdi Hu et al.

Summary: The tumor microenvironment plays a crucial role in cancer progression, including breast cancer. Cancer-associated fibroblasts (CAFs) are the most abundant components of the tumor microenvironment, promoting breast cancer malignancy through various mechanisms. CAFs have become therapeutic targets due to their unique distribution and biomarkers in tumors. Drugs interrupting the effects of CAFs on surrounding cells have been developed and applied in clinical trials. Summarizing CAF-related studies from a historical perspective can help accelerate the development of CAF-targeted therapeutic strategies for breast cancer.

CANCER COMMUNICATIONS (2022)

Article Oncology

DDR1 functions as an immune negative factor in colorectal cancer by regulating tumor-infiltrating T cells through IL-18

Xiaofan Duan et al.

Summary: This study found that DDR1 is highly expressed in colorectal cancer tissues and negatively associated with patient survival. DDR1 promotes colorectal tumor growth in vivo and acts as a negative immunomodulator in colorectal cancer by inhibiting IL-18 synthesis and enhancing PD-L1 expression through the JNK signaling pathway.

CANCER SCIENCE (2022)

Article Multidisciplinary Sciences

Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment

Han Luo et al.

Summary: This study conducts pan-cancer analysis on 226 samples across 10 solid cancer types, illustrating the commonalities and plasticity of heterogeneous CAFs. It reveals that the activation trajectory of major CAF types is divided into three states, showing distinct interactions with other cell components and correlation with immunotherapy prognosis. Additionally, minor CAF components may originate from other TME components such as endothelial cells and macrophages.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis

Michael Papanicolaou et al.

Summary: The distribution and organization of matrix molecules, particularly collagen I, in the tumor stroma play an important role in breast cancer progression. Cancer-associated fibroblasts (CAFs) remodel the extracellular matrix (ECM) to promote or inhibit tumor growth. It has been found that CAF-secreted collagen XII can alter the organization of collagen I, creating a pro-invasive microenvironment that supports metastatic dissemination. Collagen XII may serve as an indicator of breast cancer patients at high risk of metastatic relapse.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy

Shijun Ma et al.

Summary: This study reveals that hypoxia-induced epigenetic suppression of effector gene expression leads to dysfunction of T and NK cells, resulting in resistance to anti-PD1 blockade in triple negative breast cancer. Targeting hypoxia and the associated epigenetic machinery can reverse immune effector dysfunction and overcome immune resistance.

NATURE COMMUNICATIONS (2022)

Review Oncology

The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities

Yohei Masugi

Summary: Pancreatic cancer is a highly malignant disease with a complex desmoplastic stroma playing crucial roles in its pathobiology. Recent technologies have highlighted the complexity of the stroma in pancreatic cancer and the potential therapeutic opportunities it presents. Abundant desmoplastic stroma is a histological hallmark of pancreatic ductal adenocarcinoma.

CANCERS (2022)

Article Medicine, Research & Experimental

The UIP/IPF fibroblastic focus is a collagen biosynthesis factory embedded in a distinct extracellular matrix

Jeremy A. Herrera et al.

Summary: Usual interstitial pneumonia (UIP) is a characteristic pattern of idiopathic pulmonary fibrosis (IPF), where normal lung tissue is adjacent to dense fibrotic tissue. This study found that fibroblastic foci (FF), located at the interface between normal and fibrotic tissue, are the main site of collagen biosynthesis in UIP/IPF. The adjacent alveoli were also found to be abnormal. These findings provide important information for future research on the progression of fibrosis.

JCI INSIGHT (2022)

Review Biochemistry & Molecular Biology

Targeting the tumor stroma for cancer therapy

Maosen Xu et al.

Summary: Tumors are composed of cancer cells and the surrounding stromal components, and there are important interactions between the stromal components and tumor cells. Significant progress has been made in the study of tumor stroma, and clinical trials targeting the tumor stroma are ongoing. This review summarizes the latest research on the interaction between stromal components and tumor cells, and proposes potential novel approaches for tumor-stroma-based therapeutic targeting.

MOLECULAR CANCER (2022)

Article Multidisciplinary Sciences

LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity

Akshay T. Krishnamurty et al.

Summary: The study reveals the crucial role of TGF beta-dependent LRRC15(+) CAFs in tumor growth, as well as their direct impact on CD8(+) T cell function and responsiveness to checkpoint blockade.

NATURE (2022)

Article Oncology

Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumor

John A. Grout et al.

Summary: This study identifies two populations of cancer-associated fibroblasts (CAF) in lung tumors that are associated with T-cell exclusion. These populations orchestrate a specific structural tissue organization and produce distinct matrix molecules. The findings highlight the importance of targeting these CAF populations to increase immunotherapy efficacy in patients with T cell-excluded tumors.

CANCER DISCOVERY (2022)

Review Biochemistry & Molecular Biology

Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components

Sheng-Kai Hsu et al.

Summary: This review discusses the treatment resistance and tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC). By analyzing the interaction of complex environmental components, new insights into clinical applications such as personalized medicine and disease monitoring are provided.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Review Oncology

Cytotoxic CD8+T cells in cancer and cancer immunotherapy

Hans Raskov et al.

Summary: The functions and interactions between the innate and adaptive immune systems play a crucial role in anticancer immunity. Cytotoxic T cells with CD8 as the most effective effectors in the anticancer immune response form the basis of successful cancer immunotherapies. Advancements in genetically modified or synthetic receptors on cytotoxic T cells are being developed for future cancer treatment. Combinatory regimens may optimize treatment effects and reduce adverse events in cancer therapy.

BRITISH JOURNAL OF CANCER (2021)

Review Biochemistry & Molecular Biology

Tumor-associated macrophages in immunotherapy

Shijia Yan et al.

Summary: Tumor-associated macrophages (TAMs) play essential roles in tumor progression and metastasis by promoting angiogenesis, immunosuppression, and fibrotic activities. While immunotherapy has shown promising results in eradicating cancer cells by activating the innate immune system, the tumor-suppressive environment is crucial in cancer relapse.

FEBS JOURNAL (2021)

Review Health Care Sciences & Services

Comparison between the first-line and second-line immunotherapy drugs in the progression-free survival and overall survival in advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials

Shengyu Wu et al.

Summary: The meta-analysis compared the effects of first-line and second-line single immunotherapy drug treatments in patients with non-small cell lung cancer, with results showing that first-line treatment was better in terms of progression-free survival and overall survival.

ANNALS OF PALLIATIVE MEDICINE (2021)

Review Biochemistry & Molecular Biology

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

Xiaoqi Mao et al.

Summary: CAFs, as a crucial component of TME, play significant roles in promoting tumor growth, invasion, and metastasis. The interaction between CAFs and tumor cells, as well as immune cells in TIME, is critical for tumor progression.

MOLECULAR CANCER (2021)

Article Multidisciplinary Sciences

Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion

Xiujie Sun et al.

Summary: The study identifies a new mechanism of immune exclusion mediated by DDR1-ECD through promoting collagen fiber alignment. Inhibition of DDR1 promotes intratumoral penetration of T cells and eradicates tumor growth in TNBC.

NATURE (2021)

Article Biochemistry & Molecular Biology

Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation

Man Yu et al.

Summary: The study reveals that IFN-gamma promotes nuclear translocation and phase separation of YAP in tumor cells, which may contribute to the adaptive resistance to immunotherapy in solid tumors.

MOLECULAR CELL (2021)

Review Gastroenterology & Hepatology

T cells in pancreatic cancer stroma

Michelle R. Goulart et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) has a complex tumour microenvironment with immune-suppressive cells, creating an immune-privileged microenvironment that allows tumor cells to escape immune surveillance.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Review Oncology

Macrophages and Extracellular Matrix in Breast Cancer: Partners in Crime or Protective Allies?

Claire Deligne et al.

Summary: The article discusses the interactions between tumor-associated macrophages and matrix molecules in the tumor microenvironment of breast cancer, and how these pathways can be targeted for new immunotherapies for hard to treat desmoplastic tumors.

FRONTIERS IN ONCOLOGY (2021)

Article Medicine, Research & Experimental

Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression

Devadarssen Murdamoothoo et al.

Summary: The study found that tenascin-C inhibits CD8 T cell infiltration by inducing CXCL12, which may contribute to the low response rates of immune checkpoint therapy in cancer treatment. Blocking the CXCR4 receptor of CXCL12 enhances macrophage and CD8 T cell infiltration, reducing tumor growth and metastasis.

EMBO MOLECULAR MEDICINE (2021)

Review Oncology

Interplay between Cellular and Non-Cellular Components of the Tumour Microenvironment in Hepatocellular Carcinoma

Tamas Suekei et al.

Summary: Hepatocellular carcinoma is a common and deadly cancer, with current treatments offering poor survival rates. Targeting the tumour microenvironment, specifically the extracellular matrix, has shown promise in improving therapeutic strategies. Understanding the alterations in the ECM and its interactions with immune cells in HCC is crucial for developing effective treatments. Incorporating TME components into advanced cancer modelling techniques is essential for better replicating the complex interactions within the microenvironment.

CANCERS (2021)

Article Oncology

Cancer-Associated Fibroblasts Promote the Upregulation of PD-L1 Expression Through Akt Phosphorylation in Colorectal Cancer

Yang Gao et al.

Summary: Upregulation of PD-L1 expression in colorectal cancer by cancer-associated fibroblasts (CAFs) through AKT activation is one of the molecular mechanisms of tumor immune escape, negatively impacting disease-free survival (DFS) of CRC patients. Targeted anti-CAF therapy may enhance the efficacy of immunotherapy.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting

Tetiana Hourani et al.

Summary: The tumor microenvironment plays a crucial role in tumorigenesis, with TAMs being closely associated with tumor progression, therapy resistance, and poor survival rates. Targeting TAMs has become an increasingly explored strategy in cancer treatment, with efforts focused on methods like blocking recruitment, stimulating repolarization, and depletion. Additionally, nanomaterials are being investigated for their potential in precise delivery of chemotherapeutic cargo to TAMs.

FRONTIERS IN ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma

Long Liu et al.

Summary: The study developed a fibrosis-associated signature (FAIS), which was proved to be an independent prognostic predictor of overall survival and recurrence-free survival in HCC patients. The high-risk group showed inferior prognosis with advanced clinical traits, while the low-risk group exhibited superior CD8(+) T cell infiltration and might benefit more from immunotherapy.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Review Oncology

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy

Zhaonian Hao et al.

Summary: MDSC play vital roles in cancer microenvironment, influencing the responses to immunotherapies and prognosis of cancer patients. Therefore, proposing MDSC-inhibiting strategies becomes crucial in the field of cancer immunotherapies.

BIOMARKER RESEARCH (2021)

Article Oncology

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck

Dan P. Zandberg et al.

Summary: The study analyzed the effect of anti-PD-1 therapy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (HNSCC), finding that anti-PD-1 resistance is associated with changes in tumor cell metabolism, increased tumor hypoxia, and decreased CD8+ T cell numbers. Lower tumor hypoxia was associated with increased efficacy of anti-PD-1 therapy in patients.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Review Biochemistry & Molecular Biology

Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review

Kyoko Oura et al.

Summary: Liver cancer, specifically hepatocellular carcinoma (HCC), has the fourth highest mortality rate among all cancers worldwide. Despite advancements in systemic therapy, HCC still has a poor prognosis due to drug resistance, recurrence, and metastasis. Recent therapeutic strategies, such as cancer immunosuppressive therapy utilizing immune checkpoint inhibitors (ICIs) and VEGF inhibitors, have shown promise in extending the lives of patients with advanced HCC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Profiling Cancer-Associated Fibroblasts in Melanoma

Federica Papaccio et al.

Summary: Research indicates that cancer-associated fibroblasts play significant roles in tumor growth, extracellular matrix remodeling, and inflammatory response. A thorough understanding of the melanoma-fibroblast relationship can expand treatment options.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy

Audrey Lequeux et al.

Summary: Inhibition of HIF-1 alpha transcriptional activity can increase levels of NK and CD8(+) T cells in the tumor microenvironment, enhancing the efficacy of cancer immunotherapy. Combining acriflavine can significantly improve the benefits of cancer immunotherapy based on TRP-2 peptide vaccination and anti-PD-1 blocking antibody, while melanoma patients with high CCL5 levels have a higher survival rate.

ONCOGENE (2021)

Article Multidisciplinary Sciences

Abundant intratumoral fibrosis prevents lymphocyte infiltration into peritoneal metastases of colorectal cancer

En Wang et al.

Summary: This study investigated the organ specificities of tumor-infiltrating lymphocyte (TIL) infiltration and intratumoral fibrosis in colorectal cancer, finding that high intratumoral fibrosis in peritoneal metastases prevents T lymphocytes infiltration and may lead to treatment resistance and poor prognosis.

PLOS ONE (2021)

Article Biology

Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment

Alba Nicolas-Boluda et al.

Summary: The study found that tumor stiffness is strongly correlated with tumor growth and ECM crosslinking, but negatively correlated with T cell migration. Interfering with collagen stabilization can reduce ECM content and tumor stiffness, improving T cell migration and the efficacy of anti-PD-1 blockade.
Review Oncology

Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges

Ashleigh R. Poh et al.

Summary: Macrophages play a crucial role in the pancreatic tumor microenvironment and are associated with poor patient survival. Pre-clinical studies have shown the diverse contributions of macrophages in PDAC development, however, the effectiveness of macrophage-targeting therapies in clinical trials is inconsistent.

CANCERS (2021)

Article Cell Biology

Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response

Yu Wang et al.

Summary: The study investigated the heterogeneity among PDAC patients in terms of CAFs, ductal cancer cells, and immune cells, revealing differences between dense-type and loose-type PDAC. A novel subtype of CAFs, meCAFs, was discovered in loose-type PDAC, playing a critical role in disease progression and response to immunotherapy. This finding highlights the importance of considering intertumoral heterogeneity in PDAC treatment strategies.

CELL DISCOVERY (2021)

Review Oncology

The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy

Bonnie L. Russell et al.

Summary: Cancer cells present a variety of antigens to the immune system through genetic and epigenetic alterations, activating naive T cells to mount an anticancer response. Maintaining a balance between costimulatory and inhibitory signals at the immune synapse is crucial for optimum activation signal amplitude. Immune checkpoint inhibitors have emerged as a powerful anticancer therapy, but resistance mechanisms pose a challenge.

FRONTIERS IN ONCOLOGY (2021)

Review Immunology

Fibroblasts as immune regulators in infection, inflammation and cancer

Sarah Davidson et al.

Summary: In different tissues and diseases, fibroblasts play a crucial role in regulating local immune responses by modulating inflammatory or immunosuppressive activities. Their diverse immunological properties highlight the importance of tissue context in determining fibroblast-immune cell interactions.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Medicine, Research & Experimental

Turning cold tumors into hot tumors by improving T-cell infiltration

Yuan-Tong Liu et al.

Summary: Immunotherapy, particularly through immune checkpoint inhibitors, has significantly improved the treatment of malignant tumors by enhancing T cell infiltration into tumors. Understanding the mechanisms underlying cold tumors, which lack T cell infiltration, is crucial to improving immunotherapy efficacy. Strategies to transform cold tumors into hot tumors and increase T cell infiltration are discussed, along with the potential of nanomedicines in enhancing tumor immunotherapy.

THERANOSTICS (2021)

Review Biochemistry & Molecular Biology

Biological bases of cancer immunotherapy

Maryanne M. Gonzales Carazas et al.

Summary: Immunotherapy has made significant strides in cancer treatment, although challenges such as high cost, resistance, and variability of responses persist. The search for better predictive biomarkers shows promise in addressing these obstacles.

EXPERT REVIEWS IN MOLECULAR MEDICINE (2021)

Review Oncology

The matrix in cancer

Thomas R. Cox

Summary: Alterations in the extracellular matrix play a crucial role in the development and progression of solid tumours, and our understanding of matrix biology is expanding. New approaches targeting the matrix in cancer are being developed.

NATURE REVIEWS CANCER (2021)

Review Cell & Tissue Engineering

Extracellular Matrix Remodeling and Development of Cancer

Koyeli Girigoswami et al.

Summary: This article discusses the importance of stem cell growth and fate in therapy and regeneration, particularly their role in repairing damage. It also points out that the tumor microenvironment may affect the growth of stem cells, and details how uncontrolled cell growth in cancer changes the extracellular matrix (ECM).

STEM CELL REVIEWS AND REPORTS (2021)

Review Oncology

Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins

Cedric Zeltz et al.

SEMINARS IN CANCER BIOLOGY (2020)

Article Cell Biology

Conjunction junction, what's the function? CCN proteins as targets in fibrosis and cancers

Andrew Leask

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2020)

Review Oncology

A review of cancer immunotherapy toxicity

Lucy Boyce Kennedy et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Biochemistry & Molecular Biology

Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma

Jia-qiao Fan et al.

MOLECULAR CANCER (2020)

Editorial Material Oncology

Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?

Jacob J. Adashek et al.

ONCOLOGIST (2020)

Review Biochemistry & Molecular Biology

Fibrosis and cancer: A strained relationship

Bram Piersma et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Article Biochemistry & Molecular Biology

Yap suppresses T-cell function and infiltration in the tumor microenvironment

Eleni Stampouloglou et al.

PLOS BIOLOGY (2020)

Review Immunology

The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses

Alireza Labani-Motlagh et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Gastroenterology & Hepatology

Pancreatic cancer stroma: an update on therapeutic targeting strategies

Abdel N. Hosein et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Biochemistry & Molecular Biology

The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors

Evangelos Koustas et al.

BIOMOLECULES (2020)

Review Gastroenterology & Hepatology

Desmoplasia and Biophysics in Pancreatic Ductal Adenocarcinoma Can We Learn From Breast Cancer?

Francesco Di Maggio et al.

PANCREAS (2020)

Review Cell Biology

Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors

Emmanuel Donnadieu et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2020)

Article Biochemistry & Molecular Biology

The tumor microenvironment

Nicole M. Anderson et al.

CURRENT BIOLOGY (2020)

Editorial Material Immunology

T cells in COVID-19-united in diversity

Leo Swadling et al.

NATURE IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion

David H. Peng et al.

NATURE COMMUNICATIONS (2020)

Review Immunology

Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts

Xueke Shi et al.

BIOMOLECULES (2020)

Article Oncology

A framework for advancing our understanding of cancer-associated fibroblasts

Erik Sahai et al.

NATURE REVIEWS CANCER (2020)

Review Immunology

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Alex D. Waldman et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Oncology

CD8+ T cell states in human cancer: insights from single-cell analysis

Anne M. Van der Leun et al.

NATURE REVIEWS CANCER (2020)

Review Biochemistry & Molecular Biology

Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy

Erik Henke et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Review Biochemistry & Molecular Biology

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells

Mohamed-Reda Benmebarek et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Multidisciplinary Sciences

Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer

Ivy X. Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Medical Laboratory Technology

The double edge sword of fibrosis in cancer

Chelsea Chandler et al.

TRANSLATIONAL RESEARCH (2019)

Article Oncology

Collagen density regulates the activity of tumor-infiltrating T cells

Dorota E. Kuczek et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Review Biochemistry & Molecular Biology

Stroma in normal and cancer wound healing

Eric Huet et al.

FEBS JOURNAL (2019)

Review Oncology

The Emerging Role of YAP/TAZ in Tumor Immunity

Zhaoji Pan et al.

MOLECULAR CANCER RESEARCH (2019)

Review Oncology

Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy

Tongyan Liu et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Review Oncology

The clinical role of the TME in solid cancer

Nicolas A. Giraldo et al.

BRITISH JOURNAL OF CANCER (2019)

Review Biochemistry & Molecular Biology

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape

Xianjie Jiang et al.

MOLECULAR CANCER (2019)

Article Multidisciplinary Sciences

Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody

Danbee Ha et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Immunology

The Intriguing History of Cancer Immunotherapy

Paula Dobosz et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Oncology

CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer

Brooke A. Pereira et al.

TRENDS IN CANCER (2019)

Review Oncology

Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma

S. K. Daniel et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2019)

Review Biochemistry & Molecular Biology

Current Progress in CAR-T Cell Therapy for Solid Tumors

Shuo Ma et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)

Review Pharmacology & Pharmacy

Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery

Jonas Schnittert et al.

ADVANCED DRUG DELIVERY REVIEWS (2018)

Review Medicine, Research & Experimental

The fibrotic tumor stroma

Mitsuo Yamauchi et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Biochemistry & Molecular Biology

Activation of cancer-associated fibroblasts is required for tumor neovascularization in a murine model of melanoma

James Hutchenreuther et al.

MATRIX BIOLOGY (2018)

Review Biotechnology & Applied Microbiology

Talimogene laherparepvec: First in class oncolytic virotherapy

Robert M. Conry et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)

Review Immunology

Tissue-Dependent Tumor Microenvironments and Their impact on immunotherapy Responses

Amanda J. Oliver et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Medicine, Research & Experimental

Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy

Priyamvada Jayaprakash et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Review Immunology

Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression

Kim Ohl et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Oncology

Immunotherapy and Prevention of Pancreatic Cancer

Alexander H. Morrison et al.

TRENDS IN CANCER (2018)

Review Immunology

CD4+ T cell help in cancer immunology and immunotherapy

Jannie Borst et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Article Pathology

Significance of Intratumoral Fibrosis in Clear Cell Renal Cell Carcinoma

Jae Won Joung et al.

JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2018)

Article Immunology

Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses

Byron H. Kwan et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Article Biochemistry & Molecular Biology

Towards integrating extracellular matrix and immunological pathways

David F. Boyd et al.

CYTOKINE (2017)

Article Oncology

Immunotherapy in ovarian cancer

K. Odunsi

ANNALS OF ONCOLOGY (2017)

Article Biochemistry & Molecular Biology

Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcilloma

Byung Soo Lee et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Review Oncology

Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy

Hong Jiang et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)

Article Oncology

Immunotherapy for Breast Cancer: What Are We Missing?

Robert H. Vonderheide et al.

CLINICAL CANCER RESEARCH (2017)

Review Cell Biology

The emerging role of ECM crosslinking in T cell mobility as a hallmark of immunosenescence in humans

Jean-Francois Moreau et al.

AGEING RESEARCH REVIEWS (2017)

Review Biochemistry & Molecular Biology

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Padmanee Sharma et al.

Article Immunology

Tumor macrophages are pivotal constructors of tumor collagenous matrix

Ran Afik et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2016)

Article Biochemistry & Molecular Biology

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

Hong Jiang et al.

NATURE MEDICINE (2016)

Article Oncology

Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer

Clifford J. Whatcott et al.

CLINICAL CANCER RESEARCH (2015)

Article Pharmacology & Pharmacy

Imiquimod - Its role in the treatment of cutaneous malignancies

Aditya Kumar Bubna

INDIAN JOURNAL OF PHARMACOLOGY (2015)

Article Cell Biology

Spatial organization of the tenascin-C microenvironment in experimental and human cancer

Caroline Spenle et al.

CELL ADHESION & MIGRATION (2015)

Article Oncology

Immune Escape Mechanisms as a Guide for Cancer Immunotherapy

Gregory L. Beatty et al.

CLINICAL CANCER RESEARCH (2015)

Review Immunology

tTregs, pTregs, and iTregs: similarities and differences

Ethan M. Shevach et al.

IMMUNOLOGICAL REVIEWS (2014)

Review Oncology

Hypoxia and the extracellular matrix: drivers of tumour metastasis

Daniele M. Gilkes et al.

NATURE REVIEWS CANCER (2014)

Article Multidisciplinary Sciences

Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer

Christine Feig et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Immunology

Cancer-associated fibroblasts as targets for immunotherapy

Sunitha Kakarla et al.

IMMUNOTHERAPY (2012)

Editorial Material Oncology

Desmoplasia: A Response or a Niche?

Yves A. DeClerck

CANCER DISCOVERY (2012)

Review Cell Biology

The role of the myofibroblast in tumor stroma remodeling

Marcela Otranto et al.

CELL ADHESION & MIGRATION (2012)

Article Pathology

Aligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma

Matthew W. Conklin et al.

AMERICAN JOURNAL OF PATHOLOGY (2011)

Review Immunology

Regulatory T cells: immune suppression and beyond

Yisong Y. Wan

CELLULAR & MOLECULAR IMMUNOLOGY (2010)

Review Cell Biology

Tumors as Organs: Complex Tissues that Interface with the Entire Organism

Mikala Egeblad et al.

DEVELOPMENTAL CELL (2010)

Editorial Material Immunology

How do Regulatory T Cells Work?

A. Corthay

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)

Article Immunology

Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function

Claudia C. Motran et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2008)

Review Oncology

Cellular and molecular mechanisms of fibrosis

T. A. Wynn

JOURNAL OF PATHOLOGY (2008)

Review Genetics & Heredity

Hypoxia and cancer

M. Christiane Brahimi-Horn et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2007)

Article Multidisciplinary Sciences

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi

ML Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Immunology

Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells

SJ Bensinger et al.

JOURNAL OF IMMUNOLOGY (2004)